OMER News and Press, Omeros Corporation From 07/29/22

Gainers: Ayala Pharmaceuticals ( AYLA ) +27% . GeoVax Labs ( GOVX ) +20% . Senti Biosciences ( SNTI ) +17% . Omeros ( OMER ) +15% . CVRx ( CVRX ) +9% . Losers: Nutriband ( NTRB ) -15% . Bausch Health Companies ...

- - Enrollment of PNH Patients Expected to Begin this Summer -- Omeros Corporation today announced that OMS906 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). OM...

The U.S. Food and Drug Administration (FDA) has awarded its Orphan Drug designation to commercial-stage biopharma Omeros Corporation ( NASDAQ: OMER ) for a candidate targeted at paroxysmal nocturnal hemoglobinuria (PNH) on Thursday, according to a federal registry. Accordi...

Shares of Chinook Therapeutics have reacted well recently to a surprising secondary offering conducted at $14.00, providing it with additional capital for the commercialization of atrasentan. Although only one (likely) inferior therapy has been approved for the company’s initia...

After skyrocketing by above 68.7% on Friday with no clear catalyst to speak of, Omeros (NASDAQ: OMER) stock came crashing down to earth, losing more than 33% of its value as of 3:44 p.m. on Tuesday. Given the steep run-up, it's likely that today's crash is a result of traders' takin...

On July 1, the trading day before the Independence Day holiday weekend, Omeros Corp. shares closed up ~69% . On Monday afternoon, they are down ~29% . Volume is also higher than normal. Average daily volume is ~1.4M shares. As of 120p, ~3.3m shares had traded hands. It...

Gainers: Rubicon Technology ( RBCN ) +68% . Faraday Future Intelligent Electric ( FFIE ) +65% . Ra Medical Systems ( RMED ) +61% . Xilio Therapeutics ( XLO ) +35% . Maris-Tech ( MTEK ) +35% . Lexicon Pharmaceuticals ( LXRX ...

Siyata Mobile ( SYTA ) -11% . Revelation Biosciences ( REVB ) -10% . WPP ( WPP ) -9% . Micro Focus International ( MFGP ) -9% . Mereo BioPharma Group ( MREO ) -9% . Vinco Ventures ( BBIG ) -5% . Dun & Bradstre...

Omeros has undergone a savage price discovery process yielding a possible near-term bottom <$2.00. The annual shareholder meeting provided encouraging support for Omeros bulls. Omeros is a compelling buy for experienced investors who have an appetite for high-risk biotech. ...

Gainers: Allena Pharmaceuticals ( ALNA ) +46% . Mega Matrix ( MTMT ) +43% . Faraday Future Intelligent Electric ( FFIE ) +30% . Tyra Biosciences ( TYRA ) +29% . Omeros ( OMER ) +28% . Clovis Oncology ( CLVS ) +22% . ...